Effect of Highly Active Antiretroviral Therapy (HAART) and Menopause on Risk of Progression of Cervical Dysplasia in Human Immune-Deficiency Virus- (HIV-) Infected Women

Kim, Suk Chul; Messing, Susan; Shah, Krupa; Luque, Amneris E.

doi:10.1155/2013/784718

Back to Previous Page

Effect of Highly Active Antiretroviral Therapy (HAART) and Menopause on Risk of Progression of Cervical Dysplasia in Human Immune-Deficiency Virus- (HIV-) Infected Women

Published Date:

Dec 18 2013

Publisher's site:

http://dx.doi.org/10.1155/2013/784718

Source:

Infect Dis Obstet Gynecol. 2013; 2013.

[PDF-601.91 KB]

Details:

Alternative Title:

Infect Dis Obstet Gynecol

Personal Author:

Kim, Suk Chul ; Messing, Susan ; Shah, Krupa ; Luque, Amneris E. ;

Description:

More HIV-infected women are reaching older age and menopause, but there is limited information on cervical squamous intraepithelial lesions (SILs) on these women.|To assess the effect of HAART and menopause on SILs in HIV-infected women, we reviewed the results of Papanicolaou (Pap) tests obtained between 1991 and 2011 on 245 women. Progression to SILs was determined by comparing Pap test results. The association of HAART and transition to menopause on SILs was assessed using survival analysis.|Women receiving HAART had a 52% reduced risk in the progression to SILs compared to women receiving any other antiretroviral regimen or no regimen (CI: 0.33-0.70, P = 0.0001). A greater increase of CD4(+) cell counts was associated with a greater reduction on the risk of progression to SILs. Menopausal women had a 70% higher risk of progression to SILs than premenopausal women (CI: 1.11-2.62, P < 0.0001), adjusting for HIV medications, CD4(+) count, duration of HIV infection, moderation effect of menopause by age, prior IV drug use, and smoking.|HAART had a positive long-term effect on the progression to SILs. However, being younger and menopausal increases the risk of progression.

Subject:

[+]

Pubmed ID:

24453469

Pubmed Central ID:

PMC3878554

Document Type:

Journal Article

Funding:

P30 AI078498/AI/NIAID NIH HHS/United States ; UL1 PR024160/PR/OCPHP CDC HHS/United States ;

Collection(s):

CDC Public Access

Main Document Checksum:

[+]

File Type:

Supporting Files:

	IDOG2013-784718.001.gif	image/gif
	IDOG2013-784718.001.jpg	image/jpeg
	IDOG2013-784718.002.gif	image/gif
	IDOG2013-784718.002.jpg	image/jpeg
	IDOG2013-784718.nxml	text/plain
	license.txt	text/plain

No Related Documents.

Effect of Highly Active Antiretroviral Therapy (HAART) and Menopause on Risk of Progression of Cervical Dysplasia in Human Immune-Deficiency Virus- (HIV-) Infected Women

Effect of Highly Active Antiretroviral Therapy (HAART) and Menopause on Risk of Progression of Cervical Dysplasia in Human Immune-Deficiency Virus- (HIV-) Infected Women

You May Also Like:

Have Questions?

CDC INFORMATION

CONNECT WITH CDC